Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on chiral catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101781197B reveals a high-yield route for chiral binaphthyl dicarboxylic acid. Achieve >99% optical purity without chromatography for cost-effective supply.
Patent CN1233648C reveals a novel salen catalyst enabling reusable, high-optical-purity epoxide production with significant cost and supply chain advantages.
Novel mixed-solvent synthesis for high-purity chiral diamine ruthenium catalysts. Reduces recrystallization needs and boosts yield for asymmetric catalysis applications.
Patent CN104725173A reveals a novel Rhodium-catalyzed asymmetric hydrogenation method for high-purity optically active aldehydes, offering significant cost reduction and supply chain reliability for fragrance manufacturers.
Patent CN109970713B details novel amino acid-based Ir(III) catalysts enabling high-efficiency asymmetric C-H activation for cost-effective API manufacturing.
Patent CN103087105A discloses novel chiral phosphine ligands enabling high-efficiency asymmetric hydrogenation of beta-aryl enamides with exceptional enantioselectivity.
Patent CN114835541A details a Pd-catalyzed method for high-yield chiral allenoic acids. Offers superior atom economy and scalability for pharmaceutical intermediate manufacturing.
Patent CN1463272A reveals a novel chiral salen catalyst enabling racemization-free production of chiral epoxides with enhanced supply chain reliability and cost efficiency.
Patent CN105879905A introduces a novel chiral phosphine catalyst enabling high enantioselectivity in cross Rauhut-Currier reactions, offering significant supply chain and cost advantages.
Patent CN106111189B reveals a novel chiral pyridoxamine catalyst enabling mild synthesis of alpha-amino acids with high ee values and scalable manufacturing potential.
Novel cyclic phosphine catalyst Le-Phos enables high-yield asymmetric gamma-addition. Efficient synthesis route reduces costs for API manufacturing.
Novel bisaryl substituted catalyst enables high stereoselectivity. Reduces manufacturing costs and ensures supply chain reliability for complex pharmaceutical intermediate production.
Patent CN113980053A discloses novel chiral thioether-phosphine ligands enabling efficient palladium-catalyzed asymmetric allylic alkylation with high yields.
Novel 5-step synthesis route for chiral phenylglycine catalysts. High yield, mild conditions, scalable for pharma intermediates.
Novel patent CN116655694A enables metal-free synthesis. Delivers high purity catalysts for asymmetric reactions with reduced supply chain complexity and cost.
Novel axon-labile chiral ligands enable efficient asymmetric catalysis without resolution. Reduces cost and waste in pharmaceutical intermediate manufacturing.
Patent CN1075055C details a novel one-pot reduction of amino acids to amino alcohols using unactivated borohydrides, offering significant cost reduction and high chiral purity for pharmaceutical manufacturing.
Patent CN116813659A introduces a threonine-based chiral catalyst enabling high enantioselectivity and cost-effective manufacturing for complex pharmaceutical intermediates.
Novel pyridine-amide-oxazoline ligands for asymmetric hydroboration. High yield synthesis over 80 percent. Reliable supplier for pharma intermediates.
Patent CN107021884A reveals high-efficiency Ir/f-amphox catalysis for chiral 1,2-amino alcohols, offering superior TON and enantioselectivity for pharmaceutical manufacturing.